AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMIKACINE

10 registrations across 3 African markets— 9 active

Markets with AMIKACINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
MIACIN
Solution injectable / 500 MG
🇹🇳TunisiaHIKMA PharmaceuticalsexpiredOct 1991
AMIKACINE BIOTIS PHARMA
ampoule injectable / 500 mg
🇸🇳SenegalBIOTIS PHARMAactive
AMIKACINE BIOTIS PHARMA
ampoule injectable / 250 mg
🇸🇳SenegalBIOTIS PHARMAactive
AMIKACINE MYLAN
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
AMIKLIN
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
AMIKLIN
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
AMIKACINE MYLAN
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
AMIKACINE MYLAN
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
AMIKACINE MYLAN
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
AMICIN
ampoule injectable / 500 mg
🇸🇳SenegalBIOCHEM PHARMACEUTICAL INDUSTRIES LTDactive

AMIKACINE in Africa — Regulatory Overview

AMIKACINE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 9 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.